Prenatal programming: Adverse cardiac programming by gestational testosterone excess

Keyphrases

• Adulthood 33%
• Adverse Events 33%
• Bioavailable Testosterone 100%
• Brain Natriuretic Peptide 33%
• Cardiac Hypertrophy 66%
• Cardiac Left Ventricle 33%
• Cardiac Stress 33%
• Cardiomyocytes 33%
• Cardiovascular Disease 33%
• Early Postnatal Period 33%
• Female Offspring 33%
• Gene Expression 33%
• Histological Investigation 33%
• Hypertension 33%
• Insulin Receptor Substrate 1 (IRS1) 33%
• Insulin Resistance 33%
• Insulin Signaling 100%
• Left Ventricular Function 33%
• Left Ventricular Remodeling 33%
• Mammalian Target of Rapamycin (mTOR) 66%
• Metabolic Programming 33%
• Molecular Markers 66%
• Myocardial Disarray 33%
• Nuclear Factor of Activated T Cells 33%
• Oil Control 33%
• Phosphoinositide 3-kinase (PI3K) 66%
• Phosphorylation 33%
• Polycystic Ovary Syndrome 33%
• Prenatal Exposure 33%
• Prenatal Programming 100%
• Sheep 66%
• Testosterone 33%
• Two-year-olds 33%
• Ventricular Tissue 33%
• Young Female 33%

Medicine and Dentistry

• Adverse Event 33%
• Brain Natriuretic Peptide 33%
• Cardiac Muscle Cell 33%
• Cardiovascular Disease 33%
• Gene Expression 33%
• Heart Stress 33%
• Heart Ventricle Remodeling 33%
• Insulin Receptor Substrate 1 33%
• Insulin Resistance 33%
• Insulin Signaling 100%
• Left Ventricle 33%
• Mammalian Target of Rapamycin 33%
• Mammalian Target of Rapamycin Complex 1 33%
• Molecular Marker 66%
• Offspring 33%
• Perinatal Period 33%
• Phosphoinositide 3-Kinase 66%
• Polycystic Ovarian Syndrome 33%
• Pregnancy 33%
• Prenatal Exposure 33%
• Transcription Factor NFAT 33%
• Ventricular Hypertrophy 66%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 50%
• Brain Natriuretic Peptide 50%
• Cardiovascular Disease 50%
• Ewe 50%
• Heart Stress 50%
• Heart Ventricle Hypertrophy 100%
• Heart Ventricle Remodeling 50%
• Insulin Receptor Substrate 1 50%
• Mammalian Target of Rapamycin Complex 1 50%
• Metabolic Syndrome X 50%
• Molecular Marker 100%
• Phosphatidylinositol 3 Kinase 100%
• Prenatal Exposure 50%
• Transcription Factor NFAT 50%